These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31783768)

  • 21. Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study.
    Sharma SM; Damato E; Hinchcliffe AE; Andrews CD; Myint K; Lee R; Dick AD
    Br J Ophthalmol; 2021 Sep; 105(9):1256-1262. PubMed ID: 30862619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Aalto K; Kröger L; Rebane K; Lahdenne P; Martikainen J
    Pediatr Rheumatol Online J; 2022 Nov; 20(1):97. PubMed ID: 36384562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.
    Santos-Gómez M; Calvo-Río V; Blanco R; Beltrán E; Mesquida M; Adán A; Cordero-Coma M; García-Aparicio ÁM; Valls Pascual E; Martínez-Costa L; Hernández MV; Hernandez Garfella M; González-Vela MC; Pina T; Palmou-Fontana N; Loricera J; Hernández JL; González-Gay MA
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S34-S40. PubMed ID: 27054359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Henderson LA; Zurakowski D; Angeles-Han ST; Lasky A; Rabinovich CE; Lo MS;
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):9. PubMed ID: 26879972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study.
    Funk RS; Shakhnovich V; Cho YK; Polireddy K; Jausurawong T; Gress K; Becker ML
    Pediatr Rheumatol Online J; 2021 May; 19(1):62. PubMed ID: 33933127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
    Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
    Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
    J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome.
    Chen J; Luo Y; Zhao M; Wu D; Yang Y; Zhang W; Shen M
    Arthritis Res Ther; 2019 Nov; 21(1):236. PubMed ID: 31718710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximab.
    Daniel SR; McDermott JD; Le C; Pierce CA; Ziskind MA; Ellis LA
    J Med Econ; 2018 Jul; 21(7):724-731. PubMed ID: 29718743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease.
    Benmassaoud A; Al-Taweel T; Sasson MS; Moza D; Strohl M; Kopylov U; Paradis-Surprenant L; Almaimani M; Bitton A; Afif W; Lakatos PL; Bessissow T
    Dig Dis Sci; 2018 May; 63(5):1302-1310. PubMed ID: 29243105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behçet's disease.
    Keino H; Watanabe T; Nakayama M; Komagata Y; Fukuoka K; Okada AA
    Br J Ophthalmol; 2021 Nov; 105(11):1525-1533. PubMed ID: 32972915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies.
    Fabiani C; Sota J; Rigante D; Vitale A; Emmi G; Lopalco G; Vannozzi L; Guerriero S; Bitossi A; Orlando I; Franceschini R; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2018 Oct; 37(10):2805-2809. PubMed ID: 29766375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Infliximab for Early Remission Induction in Refractory Uveoretinitis Associated with Behçet Disease: A 2-year Follow-up Study.
    Keino H; Okada AA; Watanabe T; Nakayama M; Nakamura T
    Ocul Immunol Inflamm; 2017 Feb; 25(1):46-51. PubMed ID: 27767359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication.
    Heiligenhaus A; Mingels A; Heinz C; Ganser G
    Eur J Ophthalmol; 2007; 17(5):743-8. PubMed ID: 17932849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.
    Guzelant G; Ucar D; Esatoglu SN; Hatemi G; Ozyazgan Y; Yurdakul S; Seyahi E; Yazici H; Hamuryudan V
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):86-89. PubMed ID: 29148418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing biological disease modifying treatment for paediatric uveitis in the real world.
    Oh LJ; Nguyen CL; Phan K; Wong E; Zagora S; Singh-Grewal D; Chaitow J; Grigg JR; McCluskey P
    Clin Exp Ophthalmol; 2019 Aug; 47(6):741-748. PubMed ID: 30834650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis.
    Mase O; Qasem M; Beare N
    BMJ Open Ophthalmol; 2023 Jun; 8(1):. PubMed ID: 37493653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.
    Fabiani C; Sota J; Vitale A; Emmi G; Vannozzi L; Bacherini D; Lopalco G; Guerriero S; Venerito V; Orlando I; Franceschini R; Fusco F; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Ocul Immunol Inflamm; 2019; 27(1):34-39. PubMed ID: 29099660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis.
    Pérez-Guijo VC; Cravo AR; Castro Mdel C; Font P; Muñoz-Gomariz E; Collantes-Estevez E
    Joint Bone Spine; 2007 May; 74(3):254-8. PubMed ID: 17387031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.